Home » Stocks » AXIM Biotechnologies

AXIM Biotechnologies, Inc. (AXIM)

Stock Price: $0.820 USD 0.010 (1.25%)
Updated Aug 7, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 107.49M
Revenue (ttm) 789,562
Net Income (ttm) -6.13M
Shares Out 131.09M
EPS (ttm) -0.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $0.820
Previous Close $0.810
Change ($) 0.010
Change (%) 1.25%
Day's Open 0.830
Day's Range 0.800 - 0.830
Day's Volume 191,513
52-Week Range 0.100 - 1.440

More Stats

Market Cap 107.49M
Enterprise Value 113.34M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 131.09M
Float 84.23M
EPS (basic) -0.09
EPS (diluted) -0.09
FCF / Share -0.07
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta -0.41
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 136.14
PB Ratio n/a
Revenue 789,562
Operating Income -6.06M
Net Income -6.13M
Free Cash Flow -5.40M
Net Cash -5.85M
Net Cash / Share -0.04
Gross Margin 28.34%
Operating Margin -767.47%
Profit Margin -776.80%
FCF Margin -684.28%
ROA -54.36%
ROE n/a
ROIC -126.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth308.7%311.19%1.09%-4.23%---333.33%-
Gross Profit0.220.19--0.11---0.040.01
Operating Income-6.51-5.04-3.15-3.76-10.05-0.51--0.01-
Net Income-6.45-6.75-4.17-5.81-10.09-0.58-0.09-0.01-
Shares Outstanding61.9557.2853.3041.7337.0533.0033.0033.0023.28
Earnings Per Share-0.10-0.12-0.08-0.17-0.27-0.02---
Operating Cash Flow-5.02-4.85-3.08-1.29-1.54-0.34-0.030.02-
Capital Expenditures-----0.02----
Free Cash Flow-5.02-4.85-3.08-1.29-1.56-0.34-0.030.02-
Cash & Equivalents0.761.962.
Total Debt6.105.876.401.771.521.050.050.05-
Net Cash / Debt-5.35-3.91-4.34-0.55-1.38-0.38-0.05-0.030.02
Book Value-6.76-6.08-6.28-2.37-1.70-0.58-0.09-0.01
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name AXIM Biotechnologies, Inc.
Country United States
Employees 3
CEO John W. Huemoeller

Stock Information

Ticker Symbol AXIM
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: AXIM


AXIM Biotechnologies, Inc. is a vertically integrated research and development company focused on changing diagnosis and treatment for oncology and SARS-CoV-2 (COVID-19). The company's NeuCovix is the rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells. It is developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was founded in 2010 and is headquartered in San Diego, California.